Arrowstreet Capital’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-106,862
| Closed | -$5.52M | – | 1525 |
|
|
2022
Q3 | $5.52M | Buy |
+106,862
| New | +$5.52M | 0.01% | 639 |
|
|
2019
Q3 | – | Sell |
-24,700
| Closed | -$230K | – | 1773 |
|
|
2019
Q2 | $230K | Sell |
24,700
-300,048
| -92% | -$2.79M | ﹤0.01% | 1293 |
|
|
2019
Q1 | $4.51M | Buy |
324,748
+104,744
| +48% | +$1.45M | 0.01% | 826 |
|
|
2018
Q4 | $2.4M | Buy |
220,004
+9,242
| +4% | +$101K | 0.01% | 737 |
|
|
2018
Q3 | $2.66M | Buy |
210,762
+115,268
| +121% | +$1.46M | 0.01% | 644 |
|
|
2018
Q2 | $1.26M | Buy |
95,494
+61,278
| +179% | +$807K | ﹤0.01% | 761 |
|
|
2018
Q1 | $465K | Buy |
34,216
+8,200
| +32% | +$111K | ﹤0.01% | 962 |
|
|
2017
Q4 | $155K | Buy |
26,016
+8,017
| +45% | +$47.8K | ﹤0.01% | 1192 |
|
|
2017
Q3 | $134K | Buy |
+17,999
| New | +$134K | ﹤0.01% | 1068 |
|